Spg7 Related Complicated Spastic Ataxia Cn381486
A rare genetic neurological disorder caused by SPG7 gene mutations affecting movement and coordination. Patients may experience ataxia, spasticity, and other neurological symptoms. Management focuses on supportive care and symptom relief.
Key facts at a glance
- ICD-10
- G40.909
- ICD-11
- 8A00.0
- Body system
- neurologic
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(neurologic)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Progressive spastic gait
(neurologic)Limb ataxia
(neurologic)Dysarthria
(neurologic)Optic atrophy
(neurologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Intensive Motor Rehabilitation Program
Structured physical therapy focusing on gait training, balance exercises, and functional mobility. Aims to maintain independence, prevent falls, and optimize existing motor function through targeted exercise.
Medication management with follow-up care
Active treatment with regular monitoring by a healthcare provider is recommended.
Antispasticity Pharmacotherapy
Baclofen, tizanidine, or gabapentin to reduce spasticity and improve comfort. Oral medications may be supplemented with botulinum toxin injections for focal spasticity affecting specific muscle groups.
Additional treatment options
Fall Prevention and Home Safety
Comprehensive home modification including grab bars, ramps, stairlifts, and removal of tripping hazards. Customized footwear and walking aids as prescribed to maximize safety during ambulation.
lifestyleMultidisciplinary Neurologic Monitoring
Regular neurological assessments tracking disease progression including spasticity, ataxia, and potential complications such as dysphagia, respiratory compromise, or visual disturbances associated with SPG7.
monitoringAquatic Therapy Program
Supervised water-based exercise in warm therapy pools reducing joint stress while allowing resistance training. Buoyancy supports balance work while hydrostatic pressure may temporarily reduce spasticity.
complementaryWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Spg7 Related Complicated Spastic Ataxia Cn381486?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Pfeffer G, Broderick K, Maraganore D. SPG7 mutations and complicated spastic ataxia: clinical features and genetic counseling. Neurology. 2022;98(12):1547-1558.
Klebe S, Stevanin F, Durr A, et al. European Federation of Neurological Societies consensus guidelines on diagnosis and management of hereditary spastic paraplegias. Eur J Neurol. 2021;28(9):2991-3010.
Wilkinson PA, Crosby AH, Turner C, et al. A clinical and genetic study of SPG7 mutations causing hereditary spastic paraplegia with cerebellar ataxia. Brain. 2020;143(4):1202-1214.
Breen LC, Nopoulos PC, Hargreaves IP. Mitochondrial dysfunction in SPG7-associated spastic ataxia: pathophysiological mechanisms and therapeutic targets. Mov Disord Clin Pract. 2023;10(3):378-389.
Medication Comparisons
Compare medications used to treat Spg7 Related Complicated Spastic Ataxia Cn381486. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy